Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2016 Jun 22;22(9):1636–1645. doi: 10.1016/j.bbmt.2016.06.012

Table 1.

Characteristics of patients (age>=16) with acute leukemia in remission receiving unrelated cord blood , 8/8 matched or 7/8 mismatched unrelated donor transplant, transplant reported to the CIBMTR between 2008 and 2011

Variable MUD
N=930
N (%)
MMUD
N=283
N (%)
UCB
N=568
N (%)
p-value

Gender, male 514(55%) 141 (50%) 267 (47%) 0.006

Age, median (range), yrs 48(16–78) 47(16–73) 43(16–72) <0.001

Karnofsky score 0.006
≥90% 599 (64%) 186(66%) 416(73%)
<90% 309 (33%) 93 (33%) 145(26%)
Missing 22 ( 2%) 4( 1%) 7( 1%)

Disease <0.001
AML 753(81%) 226 (80%) 395 (70%)
ALL 177(19%) 57 (20%) 173(30%)

Disease status 0.014
CR1 666 (72%) 196(69%) 366 (64%)
CR2 264 (28%) 87(31%) 202 (36%)

Conditioning intensity 0.001
MAC 690 (74%) 202(71%) 371 (65%)
NMA/RIC 240 (26%) 81 (29%) 197(35%)

Conditioning Regimen <0.001
Cy + TBI ± Other 264 (28%) 87(31%) 424 (75%)
TBI ± Other 113(12%) 39(14%) 51 ( 9%)
Bu + Cy ± Other 175(19%) 51 (18%) 38 ( 7%)
Melphalan ± Other 48 ( 5%) 20 ( 7%) 32 ( 6%)
Cy ± Other 17 ( 2%) 3( 1%) 4(<1%)
Bu + Flu 289(31%) 78 (28%) 15 ( 3%)
Other 24 ( 3%) 5 ( 2%) 4(<1%)

GVHD prophylaxis <0.001
CNI + MTX ± others 622 (67%) 174(61%) 16 ( 3%)
CNI + MMF± others 198(21%) 74 (26%) 472 (83%)
CNI ± others 85 ( 9%) 26 ( 9%) 59(10%)
Other/UNK 25 ( 3%) 9 ( 3%) 21 ( 4%)

ATG, yes 325 (35%) 143(50%) 122(21%) <0.001

Donor/Recipient CMV <0.001
Pos/Pos 224 (24%) 86 (30%) 0
Pos/Neg 99(11%) 37(13%) 0
Neg/Pos 323 (35%) 90 (32%) 381 (67%)
Neg/Neg 273 (29%) 69 (24%) 183(32%)
Unknown 11 ( 1%) 1 (<1%) 4(>1%)

G-CSF/GM-CSF, yes 285(31%) 91 (32%) 488 (86%) <0.001

Received IVIG, yes 191 (21%) 68 (24%) 163(29%) <0.001

Year of transplant <0.001
2008 337 (36%) 126(45%) 122(21%)
2009 295 (32%) 87(31%) 152(27%)
2010 180(20%) 51 (18%) 158(28%)
2011 109(12%) 19 ( 7%) 136(24%)